“Media reviews explain it as a loophole,” suggests Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s really intentional coverage.” Brunner has expressed irritation regarding how some coverage from the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright drugs or investigation peptides with credentialed functions https://dietrichb307hyo4.buscawiki.com/user